Neutrophil side fluorescence: a new indicator for predicting the severity of patients with bronchiectasis.

Shiqi Li, Chunxiao Yu, Hongyu Jie, Xinai Han, Shujing Zou, Quanguang Tan, Shugeng Luo, Youming Chen, Jinhong Wang
Author Information
  1. Shiqi Li: Department of Respiration, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
  2. Chunxiao Yu: Department of Gastroenterology, The Seventh Affiliated Hospital, Southern Medical University, Foshan, China.
  3. Hongyu Jie: Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
  4. Xinai Han: Guangdong Provincial Key Laboratory of Bone and Joint Degeneration Diseases, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
  5. Shujing Zou: Department of Respiration, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
  6. Quanguang Tan: Department of Respiration, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
  7. Shugeng Luo: Department of Internal Medicine, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
  8. Youming Chen: Department of Clinical Laboratory, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China. cym38432@163.com.
  9. Jinhong Wang: Department of Respiration, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China. leechy911@126.com.

Abstract

BACKGROUND: Neutrophilic inflammation in the airway is a hallmark of bronchiectasis. Neutrophil extracellular traps (NETs) have been reported to play an important role in the occurrence and development of bronchiectasis. Neutrophil side fluorescence is one of the characteristics of neutrophils that can reflect the activation of neutrophils and the formation of NETs.
OBJECTIVE: To explore the relationship between the values of neutrophil side fluorescence (NEUT-SFL) in the peripheral blood of bronchiectasis patients, and the severity of the disease.
METHODS: 82 patients with bronchiectasis from the Department of Respiratory and Critical Medicine, at the Third Affiliated Hospital of Southern Medical University and were scored with Bronchiectasis Severity Index (BSI) (2019-2021). The clinical data such as the value of NEUT-SFL, neutrophil count, C-reactive protein, and procalcitonin levels were collected and retrospectively analyzed. NEUT-SFL values neutrophil count from 28 healthy subjects were also used to ascertain cut-off values.
RESULTS: Based on the BSI scores, patients were divided into three categories as mild (32%), moderate (29%), and severe (39%). Our results showed that the values of NEUT-SFL were higher in bronchiectasis patients compared to healthy controls. The levels of NEUT-SFL positively correlated with the high BSI scores in patients (P = 0.037, r = 0.23) and negatively correlated with the lung function in these patients (r = - 0.35, P = 0.001). The area under the ROC curve was 0.813, the best cut-off was 42.145, indicating that NEUT-SFL values > 42.145 can potentially predict the severity of bronchiectasis.
CONCLUSIONS: The values of NEUT-SFL in the peripheral blood can be used for predicting the severity of bronchiectasis.

Keywords

References

  1. Am J Respir Crit Care Med. 2019 Oct 15;200(8):992-1001 [PMID: 31264895]
  2. Thorax. 2020 Feb;75(2):164-171 [PMID: 31732687]
  3. Int J Lab Hematol. 2015 Apr;37(2):190-8 [PMID: 24867378]
  4. Eur Respir J. 2016 Feb;47(2):382-4 [PMID: 26828048]
  5. Respirology. 2016 Apr;21(3):467-75 [PMID: 26804470]
  6. Mediators Inflamm. 2015;2015:642503 [PMID: 26819500]
  7. J Clin Med. 2020 Nov 24;9(12): [PMID: 33255354]
  8. Cancers (Basel). 2019 Sep 07;11(9): [PMID: 31500300]
  9. Eur Respir J. 2020 Oct 22;56(4): [PMID: 32499333]
  10. Thromb Res. 2019 Nov;183:153-158 [PMID: 31678710]
  11. Respir Res. 2017 Dec 19;18(1):211 [PMID: 29258516]
  12. Pulm Pharmacol Ther. 2019 Dec;59:101856 [PMID: 31626976]
  13. Eur Respir J. 2019 Jun 13;53(6): [PMID: 31151955]
  14. Clin Microbiol Infect. 2020 Mar;26(3):313-318 [PMID: 31306794]
  15. Eur Respir J. 2016 Sep;48(3):632-47 [PMID: 27288031]
  16. Paediatr Respir Rev. 2017 Jan;21:54-61 [PMID: 27424227]
  17. Am J Respir Crit Care Med. 2012 Oct 1;186(7):657-65 [PMID: 22744718]
  18. Clin Chem Lab Med. 2016 Sep 1;54(9):1503-10 [PMID: 26910746]
  19. Lancet Respir Med. 2021 Aug;9(8):873-884 [PMID: 33609487]
  20. J Clin Med. 2016 Dec 08;5(12): [PMID: 27941638]
  21. Int J Lab Hematol. 2021 Feb;43(1):e1-e4 [PMID: 32845052]
  22. J Clin Pathol. 2018 Mar;71(3):259-266 [PMID: 28821583]
  23. Ann Am Thorac Soc. 2015 Nov;12(11):1602-11 [PMID: 26356317]
  24. Int J Lab Hematol. 2021 Apr;43(2):e64-e67 [PMID: 33079479]
  25. Crit Care Med. 2016 Nov;44(11):e1132-e1136 [PMID: 27441905]
  26. Ann Lab Med. 2016 May;36(3):244-9 [PMID: 26915613]

Grants

  1. SKLRD-OP-201804/Natural Science Foundation of Guangdong Province
  2. 31600732/National Natural Science Foundation of China

MeSH Term

Bronchiectasis
C-Reactive Protein
Humans
Leukocyte Count
Neutrophils
Retrospective Studies

Chemicals

C-Reactive Protein

Word Cloud

Created with Highcharts 10.0.0bronchiectasisNEUT-SFLpatientsNeutrophilvaluessideseverityfluorescencecanneutrophilBSIextracellulartrapsNETsneutrophilsperipheralbloodBronchiectasisdatacountlevelshealthyusedcut-offscorescorrelatedP = 0145predictingBACKGROUND:NeutrophilicinflammationairwayhallmarkreportedplayimportantroleoccurrencedevelopmentonecharacteristicsreflectactivationformationOBJECTIVE:explorerelationshipdiseaseMETHODS:82DepartmentRespiratoryCriticalMedicineThirdAffiliatedHospitalSouthernMedicalUniversityscoredSeverityIndex2019-2021clinicalvalueC-reactiveproteinprocalcitonincollectedretrospectivelyanalyzed28subjectsalsoascertainRESULTS:Baseddividedthreecategoriesmild32%moderate29%severe39%resultsshowedhighercomparedcontrolspositivelyhigh037r = 023negativelylungfunctionr = - 035001areaROCcurve0813best42indicatingvalues > 42potentiallypredictCONCLUSIONS:fluorescence:newindicatorCellpopulation

Similar Articles

Cited By